Dual [inpr]
Calcium channel blocker [phsu]
therapy [ftcn]
treatment [ftcn]
Hypertension [dsyn]
Objective [inpr]
In Vitro [inpr]
Receptor Binding [moft]
Calcium Channel Blockers [phsu]
In Vivo [spco]
Study [mnob]
Humans [humn]
Dual [inpr]
Calcium channel blocker [phsu]
therapy [ftcn]
Focus [spco]
therapy [ftcn]
Hypertension [dsyn]
Data Source [qnco]
MEDLINE [inpr]
search [inpr]
Conduct [inbe]
Literature [inpr]
channel blockers [phsu]
Study [mnob]
in vitro study [resa]
Investigations [hlca]
Evaluated [ftcn]
Receptor Binding [moft]
Interaction [ftcn]
subclasses [clas]
channel blockers [phsu]
Chosen [acty]
Study [mnob]
Humans [humn]
Clinical Trials [resa]
Evaluated [ftcn]
Dual [inpr]
therapy [ftcn]
treatment [ftcn]
Cardiovascular Diseases [dsyn]
Select [acty]
Case Reports [inpr]
Dual [inpr]
therapy [ftcn]
included [ftcn]
Article [inpr]
Data Extraction [resa]
methodology [inpr]
Conclusions [idcn]
Select [acty]
Evaluated [ftcn]
In Vitro [inpr]
Receptor Binding [moft]
Kinetics [npop]
channel blockers [phsu]
Interaction [ftcn]
Reported [inpr]
Limited [ftcn]
Information [idcn]
Dual [inpr]
therapy [ftcn]
Hypertension [dsyn]
Clinical Studies [resa]
treatment [ftcn]
ischaemic heart disease [dsyn]
reviewed [inpr]
Compared [acty]
Degree [qlco]
disease control [topp]
Blood Pressure [orgf]
Exercise Tolerance [clna]
adverse effects [ftcn]
Clinical Endpoint [clna]
pharmacologic therapy [ftcn]
synthesis [biof]
in vitro study [resa]
Identified [qlco]
Binding Sites [rcpt]
Dihydropyridine [orch, phsu]
Nifedipine [orch, phsu]
Verapamil [orch, phsu]
Benzothiazepine [orch]
Diltiazem [orch, phsu]
subclasses [clas]
channel blockers [phsu]
voltage-sensitive calcium channel [moft]
receptor [aapp, rcpt]
Dihydropyridine [orch, phsu]
binding [ftcn]
Affinity [npop]
Decreased [qnco]
Concomitant [tmco]
Verapamil [orch, phsu]
binding [ftcn]
Enhanced [acty]
Concomitant [tmco]
Diltiazem [orch, phsu]
binding [ftcn]
Dual [inpr]
therapy [ftcn]
Efficacy [qlco]
Patients [podg]
ischaemic heart disease [dsyn]
therapy [ftcn]
Limited [ftcn]
Dose [qnco]
adverse effects [ftcn]
APPEAR [qlco]
Patients [podg]
Ischaemia [dsyn]
Refractory [ftcn]
Conventional Therapy [topp]
Therapeutic [topp]
Options [ftcn]
Limited [ftcn]
contraindications [qlco]
Patients [podg]
Hypertension [dsyn]
Benefit [qnco]
Dual [inpr]
therapy [ftcn]
Evaluate [ftcn]
treatment option [topp]
recommendations [idcn]
Safety [hcpp]
Efficacy [qlco]
Dual [inpr]
therapy [ftcn]
Hypertension [dsyn]
Premature [tmco]
Conclusions [idcn]
Controlled [ftcn]
Evaluate [ftcn]
Dual [inpr]
therapy [ftcn]
treatment [ftcn]
Hypertension [dsyn]
Lacking [qlco]
treatment [ftcn]
Modality [idcn]
Future [tmco]
Investigation [hlca]
Safety [hcpp]
Efficacy [qlco]
